【Windtree Therapeutics签署5.2亿美元新融资协议， 将用于购买BNB】金色财经报道，纳斯达克上市生物技术公司Windtree Therapeutics（WINT）宣布，已签署最多5亿美元的普通股购买协议，用于建立股权信用额度（ELOC），此外，该公司还与Build and Build Corp签署了一份价值2000万美元的额外股票购买协议。 此次总融资规模最高达5.2亿美元，其中99%的资金将用于购买BNB。公司计划在获得股东批准增加普通股授权数量后正式启动资金动用。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.